Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cass (formerly X2AI) is a digital health company specializing in AI-driven mental health support through its proprietary chatbot platform, Tess. The platform utilizes natural language processing to deliver evidence-based psychological interventions, such as cognitive behavioral therapy (CBT) and mindfulness, via common messaging interfaces. Cass partners with healthcare systems, employers, and international NGOs to provide scalable, 24/7 mental health resources and crisis intervention. The company's technology is designed to improve accessibility to mental healthcare by offering immediate, low-cost support to individuals globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on X2AI.